Transplanting stem-cell derived dopamine progenitor cells into the brain to treat Parkinson’s disease is feasible, a landmark study has shown. Eight patients were transplanted in the first clinical trial, and no serious side effects linked to the transplanted cells were seen during the first year of follow‑up.
Cambridge researchers are developing implants that could help repair the brain pathways damaged by Parkinson’s disease.
Cambridge researchers will play a key role in clinical trials of a new treatment that involves transplanting healthy nerve cells into the brains of patients with Parkinson’s disease.
Why are we getting so fat? Why do teenagers really need to lie-in? And can we fix a broken brain? These are just some of the questions that will be answered at Cambridge BRAINFest 2017, a free public festival celebrating the most complex organ in the body.
The Academy of Medical Sciences has announced the election of its new Fellows, including five Cambridge University academics.
A collaboration between virologists and neuroscientists at Cambridge University has demonstrated how viruses that cross the blood/brain barrier could be exploited to slow down, or even halt, the progress of Parkinson’s and other neurodegenerative diseases.
© 2026 University of Cambridge